Hematopoietic Stem Cell TransplantationTransplantation, AutologousBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousBone MarrowOsteotomyTransplantation ConditioningBone Marrow CellsGraft vs Host DiseaseCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsStem Cell TransplantationCyclophosphamideTreatment OutcomeGraft SurvivalBone and BonesStem CellsRecurrenceWhole-Body IrradiationHematopoietic Stem CellsLiver TransplantationTransplantation ChimeraMultiple MyelomaHematopoietic Stem Cell MobilizationTissue DonorsAntigens, CD34LeukemiaAntineoplastic AgentsHematologic NeoplasmsEtoposideBusulfanAnemia, AplasticLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorHistocompatibility TestingBone Marrow PurgingBone Marrow DiseasesKidney TransplantationHistocompatibilityHematopoiesisTime FactorsSalvage TherapyTransplantation, IsogeneicRemission InductionLeukemia, Myeloid, AcuteImmunosuppressive AgentsBone Marrow ExaminationMice, Inbred C57BLBone RemodelingCell DifferentiationSurvival AnalysisMesenchymal Stem Cell TransplantationCord Blood Stem Cell TransplantationBone Marrow NeoplasmsRetrospective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionCell TransplantationTransplantation ImmunologyMelphalanDisease-Free SurvivalHepatic Veno-Occlusive DiseaseSurvival RateHeart TransplantationChemotherapy, AdjuvantMyelodysplastic SyndromesRadiation ChimeraImmunosuppressionHematologic DiseasesLeukemia, MyeloidT-LymphocytesAcute DiseaseLymphocyte DepletionColony-Forming Units AssayFollow-Up StudiesGraft vs Leukemia EffectCells, CulturedLung TransplantationHLA AntigensMyeloablative AgonistsFlow CytometryBone DensityLymphocyte TransfusionCytarabinePrognosisGraft vs Tumor EffectSevere Combined ImmunodeficiencyOrgan TransplantationCarmustineCyclosporineHodgkin DiseaseDose-Response Relationship, DrugEmbryonic Stem CellsBone ResorptionCytomegalovirus InfectionsLeukocyte TransfusionChimerismChimera